Latest news

LATEST NEWS

  • Sphingotec to Present Novel Acute Care Biomarkers and Point-of-Care Diagnostic Solutions at Medica 2019

    Sphingotec to Present Novel Acute Care Biomarkers and Point-of-Care Diagnostic Solutions at Medica 2019

  • Novel Data on sphingotec’s penKid® Kidney Function Assay to be Presented at 32nd ESICM Annual Congress 2019

    Novel Data on sphingotec’s penKid® Kidney Function Assay to be Presented at 32nd ESICM Annual Congress 2019

  • Dipeptidyl Peptidase 3 (DPP3) cause of acute myocardial depression. sphingotec launches first IVD test for DPP3 on Nexus IB10 Point-of-Care platform

    Dipeptidyl Peptidase 3 (DPP3) cause of acute myocardial depression. sphingotec launches first IVD test for DPP3 on Nexus IB10 Point-of-Care platform

  • sphingotec reveals novel results on bioactive adrenomedullin for diagnosis and therapy monitoring of septic shock at the 39th International Symposium on Intensive Care and Emergency Medicine (ISICEM)

    sphingotec reveals novel results on bioactive adrenomedullin for diagnosis and therapy monitoring of septic shock at the 39th International Symposium on Intensive Care and Emergency Medicine (ISICEM)

  • sphingotec announces new data on the kidney function marker proenkephalin (penKid®) presented at 24th International Conference on Advances in Critical Care Nephrology

    sphingotec announces new data on the kidney function marker proenkephalin (penKid®) presented at 24th International Conference on Advances in Critical Care Nephrology

  • Endothelial disruption: Rapid translation from bench to bedside 

    Endothelial disruption: Rapid translation from bench to bedside 

  • sphingotec raises €20 million from HBM and Wellington Partners

    sphingotec raises €20 million from HBM and Wellington Partners

  • sphingotec is adding an advanced POC testing platform to portfolio

    sphingotec is adding an advanced POC testing platform to portfolio

  • Medical leaders support novel theranostic approach to help patients with leaky blood vessels

    Medical leaders support novel theranostic approach to help patients with leaky blood vessels

  • Ortho Clinical Diagnostics and sphingotec Announce Strategic Agreement Regarding Novel Biomarker for Decreasing Re-hospitalizations in Heart Failure

    Ortho Clinical Diagnostics and sphingotec Announce Strategic Agreement Regarding Novel Biomarker for Decreasing Re-hospitalizations in Heart Failure

  • sphingotec Announces Collaboration with Mayo Clinic for Evaluation and Use of Biomarkers

    sphingotec Announces Collaboration with Mayo Clinic for Evaluation and Use of Biomarkers

  • Review paper on Proenkephalin as a Novel Biomarker for Kidney Function

    Review paper on Proenkephalin as a Novel Biomarker for Kidney Function

  • sphingotec and Shuwen Biotech partner to market sphingotec´s biomarkers portfolio in China

    sphingotec and Shuwen Biotech partner to market sphingotec´s biomarkers portfolio in China

  • sphingotec and bestbion dx partner to market predictive biomarkers for guidance of therapy in acute heart failure and septic shock

    sphingotec and bestbion dx partner to market predictive biomarkers for guidance of therapy in acute heart failure and septic shock

  • Good microcirculation indicates increased lifespan

    Good microcirculation indicates increased lifespan

  • Does the Hormone Neurotensin Hold the Key to a Longer Life?

    Does the Hormone Neurotensin Hold the Key to a Longer Life?

  • Survey: Majority of Women Do Not Discuss Breast Cancer Risks or Mammography Screening Limitations with Healthcare Providers

    Survey: Majority of Women Do Not Discuss Breast Cancer Risks or Mammography Screening Limitations with Healthcare Providers

  • Researchers Link Low Levels of Pro-Enkephalin to Future Breast Cancer in Healthy Women

    Researchers Link Low Levels of Pro-Enkephalin to Future Breast Cancer in Healthy Women

  • Majority of Women Do Not Discuss Breast Cancer Risks with Healthcare Providers

    Majority of Women Do Not Discuss Breast Cancer Risks with Healthcare Providers

  • sphingotec at the St. Gallen International Breast Cancer Conference

    sphingotec at the St. Gallen International Breast Cancer Conference

  • sphingotec and GeneNews Limited/Innovative Diagnostics Laboratory (IDL) Sign a Licensing and Cooperation Agreement for the U.S. Market

    sphingotec and GeneNews Limited/Innovative Diagnostics Laboratory (IDL) Sign a Licensing and Cooperation Agreement for the U.S. Market

Top